Delivery Order SPE2DB22D6029-SPE2DB25FLVXN
- Not listed
- This $26,634.92 firm fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 200 mg vials of the pharmaceutical product ANDEXXA. The contract has an ultimate completion date of October 18, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide various medications, medical supplies, and equipment to support military treatment facilities, veterans'...
- The Defense Logistics Agency (DLA) has awarded a $6,658.73 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distributor. The contract is for the delivery of ANDEXXA 200 MG VIALS and has an ultimate completion date of May 20, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999.00...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for ANDEXXA 200 MG VIALS. The $20,794.59 firm fixed price contract has a completion date of July 21, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. This delivery order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $52,774.44 firm fixed-price delivery order is for the supply of ANDEXXA 200 MG VIALS, with an ultimate completion date of October 21, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,658.73 firm fixed-price delivery order is for the supply of ANDEXXA 200 MG VIALS, a critical pharmaceutical product. The contract has an ultimate completion date of September 25, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,931.53, is for the delivery of ANDEXXA 200 MG VIALS and has an ultimate completion date of April 2, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ANDEXXA 200 mg vials. The contract, valued at $19,976.19, is a firm-fixed-price delivery order with an ultimate completion date of August 21, 2024. The award was made on July 31, 2024, and there was no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division for the delivery of 4564433758 ANDEXXA 200 MG VIALS. The contract has a firm fixed price ceiling value of $33,293.65 and a completion date of May 20, 2024. This is a delivery order contract type with no set-aside designation. AmerisourceBergen, a major pharmaceutical distribution company, has been awarded this order as part of its Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,931.53, is a delivery order for 4,568,075,871 vials of the medication ANDEXXA 200 MG. The contract is a firm fixed-price agreement with a period of performance ending on May 20, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $79,161.66 firm fixed-price delivery order is for the supply of ANDEXXA 200 MG VIALS. The contract has an ultimate completion date of November 18, 2022 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB25FLVXNDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Andexxa 200 mg vials, a critical reversal agent used in military and federal healthcare settings. The contract is valued at $6,931.53 with a firm fixed price structure and completion deadline of October 1, 2025. This award represents a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement designated SPE2DX and active through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio with DLA includes a comprehensive range of pharmaceutical products spanning multiple therapeutic domains, from specialty medications and brand-name drugs to vaccines and medical devices. This delivery order exemplifies AmerisourceBergen's role as a critical vendor within the DLA's global pharmaceutical supply chain supporting military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 9/10/25 |